Drug Recalls

Here you'll find every drug recall the FDA has issued, including prescription medications, over-the-counter drugs, compounded pharmacy products, and dietary supplements. We've been tracking these since 2006 and our database updates several times a day so you're always looking at current information.

Drugs get recalled for a number of reasons: contamination during manufacturing, incorrect potency or dosage, failed quality testing (like dissolution or stability tests), sterility problems in injectable products, or labeling and packaging errors that could cause someone to take the wrong dose. If you find a product on this list that you use, please follow the instructions provided by the FDA to take the necessary precautions.

17,529 total recalls
2 this month

Showing 2321–2340 of 17,529 recalls

March 17, 2023· Amerisource Health Services LLC

Recalled Item: Glimepiride Tablets

The Issue: CGMP Deviations: recalling drug products following an FDA

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 17, 2023· Amerisource Health Services LLC

Recalled Item: Glimepiride Tablets

The Issue: CGMP Deviations: recalling drug products following an FDA

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 17, 2023· Ascend Laboratories, LLC

Recalled Item: Aripiprazole Tablets

The Issue: Out of specification (OOS) for Spectroscopic Identification test

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
March 16, 2023· Northwind Pharmaceuticals LLC

Recalled Item: Tadalafil Tablets

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
March 16, 2023· Northwind Pharmaceuticals LLC

Recalled Item: BusPIRone Hydrochloride Tablets USP

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
March 16, 2023· Northwind Pharmaceuticals LLC

Recalled Item: Glimepiride Tablets

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
March 16, 2023· Northwind Pharmaceuticals LLC

Recalled Item: Atorvastatin Calcium Tablets

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
March 16, 2023· Northwind Pharmaceuticals LLC

Recalled Item: Doxazosin Tablets

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
March 16, 2023· Northwind Pharmaceuticals LLC

Recalled Item: Tadalafil Tablets

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
March 16, 2023· Northwind Pharmaceuticals LLC

Recalled Item: Glimepiride Tablets

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
March 16, 2023· Amerisource Health Services LLC

Recalled Item: Verapamil Hydrochloride Extended-Release Tablets

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 16, 2023· Focus Health Group Inc

Recalled Item: Epinephrine Professional EMS

The Issue: Labeling; Incorrect NDC number on outer carton of

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
March 15, 2023· Baxter Healthcare Corporation

Recalled Item: Dianeal PD-2 Peritonial Dialysis Solution with 1.5% Dextrose

The Issue: Lack of Assurance of Sterility: Potential presence of

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardCompleted
Refund
March 15, 2023· Baxter Healthcare Corporation

Recalled Item: Dianeal Low Calcium (2.5 mEq/L) Peritonial Dialysis Solution with 1.5% Dextrose

The Issue: Lack of Assurance of Sterility: Potential presence of

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardCompleted
Refund
March 14, 2023· Hetero USA Inc

Recalled Item: Pantoprazole Sodium Delayed Release Tablets USP 40mg

The Issue: CGMP Deviations: Discoloration

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
March 14, 2023· Ascend Laboratories, LLC

Recalled Item: Dabigatran Etexilate 150mg Capsules

The Issue: CGMP Deviations: Detection of N-nitroso-dabigatran (NDAB) impurity levels

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
March 14, 2023· Ascend Laboratories, LLC

Recalled Item: Dabigatran Etexilate Capsules

The Issue: CGMP Deviations: Detection of N-nitroso-dabigatran (NDAB) impurity levels

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
March 13, 2023· Camber Pharmaceuticals Inc.

Recalled Item: Atovaquone Oral Suspension USP

The Issue: Microbial Contamination of Non-Sterile Product: Objectionable organism, identifi

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
March 13, 2023· Direct Rx

Recalled Item: Simvastatin

The Issue: cGMP deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 13, 2023· Direct Rx

Recalled Item: Glimepiride

The Issue: cGMP deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund